...
首页> 外文期刊>Scientific reports. >A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8+ T Cells
【24h】

A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8+ T Cells

机译:基于脂质的抗原递送系统中有效地功能有助于MHC I类抗原呈递树突状细胞激发CD8 + T细胞

获取原文
           

摘要

The most effective strategy for protection against intracellular infections such as Leishmania is vaccination with live parasites. Use of recombinant proteins avoids the risks associated with live vaccines. However, due to low immunogenicity, they fail to trigger T cell responses particularly of CD8(+) cells requisite for persistent immunity. Previously we showed the importance of protein entrapment in cationic liposomes and MPL as adjuvant for elicitation of CD4(+) and CD8(+) T cell responses for long-term protection. In this study we investigated the role of cationic liposomes on maturation and antigen presentation capacity of dendritic cells (DCs). We observed that cationic liposomes were taken up very efficiently by DCs and transported to different cellular sites. DCs activated with liposomal rgp63 led to efficient presentation of antigen to specific CD4(+) and CD8(+) T cells. Furthermore, lymphoid CD8(+) T cells from liposomal rgp63 immunized mice demonstrated better proliferative ability when co-cultured ex vivo with stimulated DCs. Addition of MPL to vaccine enhanced the antigen presentation by DCs and induced more efficient antigen specific CD8(+) T cell responses when compared to free and liposomal antigen. These liposomal formulations presented to CD8(+) T cells through TAP-dependent MHC-I pathway offer new possibilities for a safe subunit vaccine.
机译:保护细胞内感染等最有效的保护策略是用活寄生虫接种疫苗。使用重组蛋白质避免了与活疫苗相关的风险。然而,由于低免疫性性,它们未能触发T细胞应答,特别是CD8(+)细胞的必要条件以进行持续免疫力。此前,我们展示了蛋白质夹杂物在阳离子脂质体和MPL中的重要性,作为佐剂,用于引发CD4(+)和CD8(+)T细胞对长期保护的反应。在这项研究中,我们研究了阳离子脂质体对树突细胞(DC)的成熟和抗原呈递能力的作用。我们观察到阳离子脂质体通过DCS非常有效地溶解并运输到不同的细胞位点。用脂质体RGP63激活的DC导致有效呈现抗原到特异性CD4(+)和CD8(+)T细胞。此外,来自脂质体RGP63免疫小鼠的淋巴CD8(+)T细胞在共同培养与刺激的DC中时,较好的增殖能力。添加MPL以疫苗通过DCS增强抗原呈递,并且与游离和脂质体抗原相比,诱导更有效的抗原特异性CD8(+)T细胞反应。这些脂质体制剂通过敲击依赖性MHC-I途径呈现给CD8(+)T细胞提供了一种安全亚基疫苗的新可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号